SenzaGen AB
SENZA | ST
Overview
Corporate Details
- ISIN(s):
- SE0010219626
- LEI:
- 549300SHQUZ0VQR2S848
- Country:
- Sweden
- Address:
- C/O Medicon Village, 223 81 Lund
- Website:
- https://senzagen.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Technical testing and analysis
Description
SenzaGen AB is a biotechnology company that provides animal-free, in vitro testing services for assessing the allergenicity of chemical substances. The company develops and commercializes the proprietary GARD® (Genomic Allergen Rapid Detection) test platform, which utilizes genomics and machine learning to analyze a substance's potential to cause skin or respiratory sensitization. Its flagship product, GARD®skin, is an OECD-approved test method (TG 442E) for skin sensitization. SenzaGen's technology is designed for high performance and applicability to a wide range of substances, including complex and "difficult-to-test" samples like formulations, UVCBs, and hydrophobic materials. The company serves clients in the chemical, cosmetics, pharmaceutical, and medical device industries, collaborating with industry leaders to replace traditional animal testing with more accurate and ethical alternatives.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for SenzaGen AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all SenzaGen AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SenzaGen AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
